Galacto-Oligosaccharide Market Report 2026

The galacto-oligosaccharide market size has grown strongly in recent years. It will grow from $0.92 billion in 2025 to $1.01 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing awareness of digestive health benefits, expansion of infant formula consumption, rising adoption of functional food ingredients, advancements in enzymatic production processes, growth of nutraceutical markets.

The galacto-oligosaccharide market size is expected to see strong growth in the next few years. It will grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing demand for microbiome-focused nutrition, increasing use of prebiotics in personalized diets, expansion of functional dairy alternatives, rising investment in gut health research, increasing regulatory approvals for prebiotic applications. Major trends in the forecast period include increasing use of prebiotic ingredients in functional foods, rising demand for gut health enhancers, expansion of gos use in infant nutrition, increasing adoption in dietary supplements, product innovation in low-calorie sweetening.

The rise in premature births is expected to propel the growth of the galacto-oligosaccharide market going forward. Premature birth occurs when an infant is born before completing the standard 37 weeks of gestation, potentially resulting in health issues due to the incomplete development of organs and systems. Premature births are increasing due to factors such as delayed maternal age, lifestyle choices, medical interventions, and underlying health conditions. Galacto-oligosaccharides (GOS) help support maternal and infant health by promoting a healthy gut microbiota, which can reduce inflammation and improve overall pregnancy and neonatal outcomes. For instance, in 2023, according to Tommy's, a UK-based pregnancy and baby-loss charity, premature live births rose for the third consecutive year, totaling over 48,000 cases in England and Wales. Therefore, the rise in premature births is driving the growth of the galacto-oligosaccharide market.

Major companies operating in the galacto-oligosaccharide (GOS) market are focusing on developing innovative solutions, such as synbiotic beverages, to meet the rising demand for gut health-supporting products driven by increasing consumer awareness of digestive wellness. Synbiotic beverages combine prebiotics and probiotics to create a synergistic effect that promotes a balanced gut microbiome, offering an advanced alternative to traditional probiotic drinks that contain probiotics alone. For instance, in May 2024, Clasado Biosciences, a UK-based biotech company, partnered with a Zurich-based company to launch a synbiotic water range featuring GOS as the prebiotic component alongside a probiotic element. The beverage is formulated to nourish Bifidobacteria, supporting gastrointestinal, immune, and cognitive health, and is available in three flavors: Lemon Zest & Rosehip, Raspberry & Cardamom, and Bergamot & Swiss Pine. It is designed for convenient consumption while being scientifically supported for gut health benefits.

In April 2025, Eleat Ltd., a UK-based health and nutrition company, acquired the consumer supplement range of Bimuno from Clasado Biosciences Ltd. for an undisclosed amount. Through this acquisition, Eleat Ltd. aims to expand its product portfolio and accelerate growth in the gut health and wellness supplement market by leveraging an established, science-backed brand. Clasado Biosciences Ltd. is a UK-based biotechnology company specializing in the research and development of gut-health ingredients and products, including the proprietary prebiotic Bimuno GOS.

Major companies operating in the galacto-oligosaccharide market are Cargill Incorporated, Royal Friesland Campina, Fonterra Cooperative Group Limited, Saputo Dairy UK, DuPont De Nemours, DSM, Kerry Group plc, Wacker Chemie AG, Ingredion Incorporated, Meiji Holdings Co. Ltd., Morinaga Milk Industry Co. Ltd., Yakult Honsha Co. Ltd., Samyang Corporation, Tate & Lyle, Nissin Sugar Co. Ltd., BENEO, Danone India, Biosynth, Clasado Biosciences, AIDP Inc., ZuChem Inc., Inbiose NV, VW-Ingredients, Lactose India Limited, Bioven Ingredients.

Europe was the largest region in the galacto-oligosaccharide market in 2025. The regions covered in the galacto-oligosaccharide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the galacto-oligosaccharide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The galacto-oligosaccharide market consists of sales of functional foods, dietary supplements, and infant formulas. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.